nature.com/articles/s4146…

National Board of Osteopathic Medical Examiners (NBOME): Get NBME and NBOME to update USMLE Step 1 an... chng.it/YfqHfdzG via Change.org

After 10 years in #neuroscience as an undergrad and #PhD student, I'm thrilled to announce my first ever scientific paper: Plasticity and Spontaneous Activity Pulses in Disused Human Brain Circuits cell.com/neuron/fulltex… (thread below)

Passed STEP. Nightmare over.

I'm proud to have played an extremely small role in this, but prouder of my colleagues for their hard work. Excited for what's to come!

Congratulations to virologist Charles Rice, a winner of the 2020 Nobel Prize in Physiology or Medicine, for his groundbreaking work at #WashUMed related to the hepatitis C virus. nobelprize.org/prizes/medicin…

My current version of the Prelude from Partita No. 3 in E Major by Bach on mandolin. Not very perfect. Was very fun. youtu.be/lunZXbRearg Thanks to Chris Thile for inspiring me to pick up the mandolin and demonstrating how much fun one can have playing Bach.

.C2N Diagnostics launches the PrecivityAD™ blood test; our researchers found the PrecivityAD™ test predicts #Alzheimer’s brain pathology in people with memory and thinking issues. It's now available: precivityad.com/news/alzheimer…

Nice new paper from Monica Xiong in the lab on the interesting potential advantages of a specific type of apoE antibody to target plaques and CAA....pubmed.ncbi.nlm.nih.gov/33597265/

Selective removal of astrocytic APOE4 strongly protects against tau-mediated neurodegeneration and decreases synaptic phagocytosis by microglia cell.com/neuron/fulltex… Congrats to Chao Wang and all our colleagues showing a key role for astroctye-derived apoE4 in degeneration

Amazing time with the Holtzman lab graduate student crew at the GRC in Barcelona, Spain. ⁦David Holtzman⁩ Missing a few members ⁦@dongohseo1⁩

Congrats to Xiaoying Chen and all our wonderful collaborators on this important set of findings. nature.com/articles/s4158…

Our 2023-2024 BIG seminar series speakers! Not bad at all 😉 👍👍👍 Join us this coming Thursday for ⁦Dr Sarah D Ackerman⁩’s Seminar!

A quick review I wrote with David Holtzman about some of the interesting recent developments in AD immunotherapies that are now reaching the clinics: science.org/doi/10.1126/sc…

Antibody therapies for #AlzheimersDisease like #lecanemab and #donanemab are finally moving from clinical trials to patients, write Tabor and David Holtzman in a Focus that explores opportunities and challenges with amyloid-clearing antibodies. WashU Medicine Neurology scim.ag/4Lr

sciencedirect.com/science/articl…

authors.elsevier.com/c/1iEjZL7PXmeaa